LIQUIDITY AND CAPITAL RESOURCES
## Table 0 ##
Our cash, cash equivalents, and short-term investments consist principally of money market mutual funds, municipal bonds, and United States government agency securities.
All of our cash equivalents and short-term investments are classified as available-for-sale under the provisions of SFAS 115, ‘‘Accounting for Certain Investments in Debt and Equity Securities.
’’ The securities are carried at fair value with the unrealized gains and losses, net of tax, included in accumulated other comprehensive income, which is reflected as a separate component of stockholders’ equity.
Our cash, cash equivalents, and short-term investments increased $226.2 million, or 83%, in fiscal 1999, primarily due to cash generated from operations of $334.2 million, proceeds from the issuance of treasury stock related to the exercise of stock options under our stock option plans and sale of stock under the Employee Stock Purchase Plan of $142.9 million, and the release of restricted funds totaling $130.3 million associated with the refinancing of our corporate headquarters lease agreement.
Other sources of cash include the proceeds from the sale of equity securities and the sale of a building in the amount of $63.9 million and $40.6 million, respectively.
In addition, short-term investments increased due to a reclassification of $46.7 million of investments classified as long-term to short-term as well as mark-to-market adjustments totaling $81.2 million.
These factors were partially offset by the purchase of treasury stock in the amount of $479.2 million, capital expenditures of $42.2 million, the purchase of other assets for $43.5 million, the purchase of the assets of GoLive Systems and Attitude Software for $36.9 million, and the payment of dividends totaling $12.2 million.
We expect to continue our investing activities, including expenditures for computer systems for research and development, sales and marketing, product support, and administrative staff.
Furthermore, cash reserves may be used to purchase treasury stock and acquire software companies, products, or technologies that are complementary to our business.
In September 1997, Adobe’s Board of Directors authorized, subject to certain business and market conditions, the purchase of up to 30.0 million shares of our common stock over a two-year period.
We repurchased approximately 1.7 million shares in the first quarter of fiscal 1999, 20.3 million shares in fiscal 1998, and 8.0 million shares in fiscal 1997, at a cost of $30.5 million, $362.4 million, and $188.6 million, respectively.
This program was completed during the first quarter of fiscal 1999.
In April 1999, Adobe’s Board of Directors authorized, subject to certain business and market conditions, the purchase of up to an additional 5.0 million shares of our common stock over a two-year period.
This new stock repurchase program was in addition to an existing program whereby we have been authorized to repurchase shares to offset issuances under employee stock option and stock purchase plans.
No purchases have been made under the 5.0 million share repurchase program.
Under our existing plan to repurchase shares to offset issuances under employee stock plans, we repurchased approximately 11.2 million, 0.7 million, and 4.6 million shares in fiscal 1999, 1998, and 1997, respectively, at a cost of $448.7 million, $16.8 million, and $87.0 million, respectively.
We have paid cash dividends on our common stock each quarter since the second quarter of 1988.
Adobe’s Board of Directors declared a cash dividend on our common stock of $0.025 per common share for each of the four quarters in fiscal 1999, 1998, and 1997.
On December 1, 1997, we dividended one share of Siebel common stock for each 600 shares of Adobe common stock held by stockholders of record on October 31, 1997.
An equivalent cash dividend was paid for holdings of less than 15,000 Adobe shares and
McKESSON CORPORATION FINANCIAL NOTES (Continued) Other Defined Benefit Plans Under various U. S.  bargaining unit labor contracts, we make payments into multi-employer pension plans established for union employees.
We are liable for a proportionate part of the plans’ unfunded vested benefits liabilities upon our withdrawal from the plan, however information regarding the relative position of each employer with respect to the actuarial present value of accumulated benefits and net assets available for benefits is not available.
Contributions to the plans and amounts accrued were not material for the years ended March 31, 2006, 2005 and 2004.
Defined Contribution Plans We have a contributory profit sharing investment plan (“PSIP”) for U. S.  employees not covered by collective bargaining arrangements.
Eligible employees may contribute up to 20% of their compensation to an individual retirement savings account.
Prior to 2006, the Company made matching contributions equal to or greater than 50% of employee contributions, not to exceed 3% of employee compensation.
Effective April 1, 2005, the Company makes matching contributions in an amount equal to 100% of the employee’s first 3% of pay deferred, and 50% of the employee’s deferral for the next 2% of pay deferred.
The Company provides for the PSIP contributions primarily with its common shares through its leveraged ESOP or cash payments.
The ESOP has purchased an aggregate of 24 million shares of the Company’s common stock since its inception.
These purchases were financed by 10 to 20-year loans from or guaranteed by us.
The ESOP’s outstanding borrowings are reported as long-term debt of the Company and the related receivables from the ESOP are shown as a reduction of stockholders’ equity.
The loans are repaid by the ESOP from interest earnings on cash balances and common dividends on shares not yet allocated to participants, common dividends on certain allocated shares and Company cash contributions.
The ESOP loan maturities and rates are identical to the terms of related Company borrowings.
Stock is made available from the ESOP based on debt service payments on ESOP borrowings.
Contribution expense for the PSIP in 2006, 2005 and 2004 was primarily ESOP related.
After-tax ESOP expense and other contribution expense, including interest expense on ESOP debt, was $7 million, $9 million and $8 million in 2006, 2005 and 2004.
Approximately 1 million, 1 million and 2 million shares of common stock were allocated to plan participants in 2006, 2005 and 2004.
Through March 31, 2006, 23 million common shares have been allocated to plan participants, resulting in a balance of 2 million common shares in the ESOP, which have not yet been allocated to plan participants.15.
Other Postretirement Benefits We maintain a number of postretirement benefits, consisting of healthcare and life insurance benefits, for certain eligible U. S.  employees.
Eligible employees consist of those who retired before March 31, 1999 and those who retire after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria.
We also provide postretirement benefits for certain U. S.  executives.
The measurement date for our postretirement plans is December 31.
The net periodic expense for our postretirement benefits is as follows:
## Table 1 ##
McKESSON CORPORATION FINANCIAL REVIEW (Continued) 31 The customer mix of revenues from our U. S.  Pharmaceutical Distribution business was as follows:
## Table 2 ##
As previously described, a limited number of our large retail chain customers purchase products through both our direct and warehouse distribution methods, the latter of which generally has a significantly lower gross profit margin due to the low cost-to-serve model.
When evaluating and pricing customer contracts, we do so based on our assessment of total customer profitability.
As a result, we do not evaluate our performance or allocate resources based on sales to customers’ warehouses or gross profit associated with such sales.
Canadian pharmaceutical distribution and services revenues increased 5% in 2012 compared to 2011.
Excluding a favorable foreign currency exchange rate fluctuation of 2% during 2012, revenues increased primarily due to market growth, five additional sales days and a small acquisition in the second quarter of 2011, partially offset by government-imposed price reduction for generic pharmaceuticals in certain provinces.
Canadian pharmaceutical distribution and services revenues increased 8% in 2011 compared to 2010.
Excluding a favorable foreign currency exchange rate fluctuation of 7% during 2011, revenues increased 1% in 2011.
Canadian revenues for 2011 increased due to market growth, offset by a government-imposed price reduction for generic pharmaceuticals in certain provinces and the impact of price deflation associated with brand to generic drug conversions.
Medical-Surgical distribution and services revenues increased in 2012 compared to 2011 primarily due to market growth, new customers and five additional sales days.
Medical-Surgical distribution and services revenues increased in 2011 compared to 2010 primarily due to market growth, partially offset by a decrease in demand associated with the flu season.
Technology Solutions revenues increased in 2012 compared to 2011 primarily due to higher revenues for claims processing, increased revenues associated with the sale and installation of our software products, an increase in maintenance revenues from new and existing customers and a number of small acquisitions made during 2012.
Technology Solutions revenues increased slightly in 2011 compared to 2010 primarily due to an increase in maintenance revenues from new and existing customers, increased revenues associated with the sale and installation of our software products and higher revenues for claims processing, partially offset by the sale of MAP in July 2010.
## Table 3 ##
(1) Gross profit of our Distribution Solutions segment for 2011 includes a credit of $51 million representing our share of a settlement of an antitrust class action lawsuit brought against a drug manufacturer, which was recorded as a reduction to cost of sales.
(2) Gross profit of our Technology Solutions segment for 2012 and 2011 includes a $31 million product alignment charge and a $72 million asset impairment charge for capitalized software held for sale.
McKESSON CORPORATION FINANCIAL NOTES (Continued) 86 The following table represents a reconciliation of Level 3 plan assets held during the years ended March 31, 2012 and 2011:

<table><tr><td></td><td>1999</td><td>Change</td><td>1998</td><td>Change</td><td>1997</td></tr><tr><td>Cash, cash equivalents, and short-term investments</td><td>$498.7</td><td>83%</td><td>$272.5</td><td>-46%</td><td>$503.0</td></tr><tr><td>Working capital</td><td>$355.4</td><td>73%</td><td>$205.0</td><td>-55%</td><td>$454.3</td></tr><tr><td>Stockholders' equity</td><td>$512.2</td><td>-0.8%</td><td>$516.4</td><td>-28%</td><td>$715.4</td></tr></table>
<table><tr><td></td><td colspan="3"> Years Ended March 31,</td></tr><tr><td><i>(In millions)</i></td><td> 2006</td><td> 2005</td><td> 2004</td></tr><tr><td>Service cost—benefits earned during the year</td><td>$2</td><td>$2</td><td>$2</td></tr><tr><td>Interest cost on projected benefit obligation</td><td>11</td><td>11</td><td>12</td></tr><tr><td>Amortization of unrecognized loss and priorservice costs</td><td>20</td><td>22</td><td>23</td></tr><tr><td>Net periodic postretirement expense</td><td>$33</td><td>$35</td><td>$37</td></tr></table>
<table><tr><td></td><td colspan="3"> Years Ended March 31,</td></tr><tr><td></td><td> 2012</td><td> 2011</td><td> 2010</td></tr><tr><td>Direct Sales</td><td></td><td></td><td></td></tr><tr><td>Retail Chains</td><td>34%</td><td>33%</td><td>32%</td></tr><tr><td>Institutions</td><td>34</td><td>34</td><td>32</td></tr><tr><td>Independents</td><td>11</td><td>12</td><td>12</td></tr><tr><td>Subtotal</td><td>79</td><td>79</td><td>76</td></tr><tr><td>Sales to retail customers’ warehouses</td><td>21</td><td>21</td><td>24</td></tr><tr><td>Total</td><td>100%</td><td>100%</td><td>100%</td></tr></table>
<table><tr><td></td><td colspan="3"> Years Ended March 31,</td><td colspan="2"> Change</td></tr><tr><td> <i>(Dollars in millions)</i> </td><td> 2012</td><td> 2011</td><td> 2010</td><td> 2012</td><td> 2011</td></tr><tr><td>Gross Profit</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Distribution Solutions<sup>-1</sup></td><td>$5,057</td><td>$4,565</td><td>$4,219</td><td>11%</td><td>8%</td></tr><tr><td>Technology Solutions<sup>-2</sup></td><td>1,510</td><td>1,405</td><td>1,457</td><td>7</td><td>-4</td></tr><tr><td>Total</td><td>$6,567</td><td>$5,970</td><td>$5,676</td><td>10</td><td>5</td></tr><tr><td>Gross Profit Margin</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Distribution Solutions</td><td>4.23%</td><td>4.19%</td><td>4.00%</td><td>4bp</td><td>19bp</td></tr><tr><td>Technology Solutions</td><td>45.62</td><td>43.97</td><td>46.64</td><td>165</td><td>-267</td></tr><tr><td>Total</td><td>5.35</td><td>5.33</td><td>5.22</td><td>2</td><td>11</td></tr></table>

Question: What do all Gross Profit sum up, excluding those that are smaller than 2000 million in 2012? (in million)